All the information you need about bioMérieux to develop and secure your business in France

| Deposit | Confidentiality | closing date | document |
|---|---|---|---|
| 2023-06-07 | Public | 2022-12-31 | Consolidated |
| 2022-06-29 | Public | 2021-12-31 | Complete |
| 2021-07-06 | Public | 2020-12-31 | Complete |
| 2020-07-29 | Public | 2019-12-31 | Consolidated |
| 2019-07-03 | Public | 2018-12-31 | Consolidated |
| 2018-06-12 | Public | 2017-12-31 | Simplified |
| 2017-06-27 | Public | 2016-12-31 | Complete |
| Name | bioMérieux |
| Siren | 673620399 |
| Closing | 2019-12-31 |
| Registry code | 6901 |
| Registration number | B2020/023476 |
| Management number | 1988B02984 |
| Activity code | 2120Z |
| Closing date n-1 | 2018-12-31 |
| Duration Fiscal year | 12 |
| Duration Fiscal year n-1 | 00 |
| Filing date | 2020-07-29 |
| Modification | 01 Annual accounts entered with accounting inconsistencies at document source |
| Balance sheet type | K : Consolidated |
| Currency code | EUR |
| Confidentiality | Public |
| Address | 69280 MARCY-L'ETOILE |
| 1 - Assets (balance sheet) | Gross amount N | Amortization year N | Net year N | Net year N-1 |
A1 ASSETS - Investments | 652 500 000.00 | |||
AJ Other Intangible Assets | 508 400 000.00 | |||
AT Other tangible assets | 894 700 000.00 | |||
BJ TOTAL (I) | 2 147 483 647.00 | |||
BN Goods in progress | 494 700 000.00 | |||
BX Customers and related accounts | 552 100 000.00 | |||
BZ Other receivables | 61 100 000.00 | |||
CF Cash and cash equivalents | 275 000 000.00 | |||
CJ TOTAL (II) | 1 438 500 000.00 | |||
CO Grand total (0 to V) | 2 147 483 647.00 | |||
CS Evaluated investments - equity method | 200 000.00 | |||
| 2 - Liabilities (balance sheet) | Amount year N | Amount year N-1 | ||
DA Share or individual capital | 12 000 000.00 | 12 000 000.00 | 12 000 000.00 | |
DB Share, merger, contribution premiums, etc. | 1 919 100 000.00 | 1 659 500 000.00 | 1 919 100 000.00 | |
DL TOTAL (I) | 2 147 483 647.00 | 1 928 000 000.00 | 2 147 483 647.00 | |
DP Provisions for Risks | 109 300 000.00 | 92 100 000.00 | 109 300 000.00 | |
DR TOTAL (IV) | 250 500 000.00 | 226 300 000.00 | 250 500 000.00 | |
DV Miscellaneous Loans and Financial Debts (4) | 592 300 000.00 | 654 000 000.00 | 592 300 000.00 | |
DX Trade payables and related accounts | 211 900 000.00 | 179 700 000.00 | 211 900 000.00 | |
EA Other liabilities | 381 100 000.00 | 352 200 000.00 | 381 100 000.00 | |
EC TOTAL (IV) | 1 527 300 000.00 | 1 502 400 000.00 | 1 527 300 000.00 | |
EE Grand total (I to V) | 2 147 483 647.00 | 2 147 483 647.00 | 2 147 483 647.00 | |
P2 LIABILITIES - Gross Technical Reserves | 272 800 000.00 | 256 500 000.00 | 272 800 000.00 | |
P7 LIABILITIES - Retained Earnings | 50 700 000.00 | 74 000 000.00 | 50 700 000.00 | |
P8 LIABILITIES - Profit or Loss for the Year | 141 200 000.00 | 134 200 000.00 | 141 200 000.00 | |
| 3 - Income statement | Amount France year N | Amount Export year N | Total year N | Total year N-1 |
FQ Other income | 45 900 000.00 | |||
FW Other purchases and external expenses | 1 124 100 000.00 | |||
GG - OPERATING RESULT (I - II) | 388 500 000.00 | |||
GU Total financial expenses (VI) | 2 500 000.00 | |||
GW - CURRENT INCOME BEFORE TAX (I - II + III - IV + V - VI) | 370 700 000.00 | |||
| 4 - Income statement (continued) | Amount year N | Amount year N-1 | ||
HK Income tax | 77 800 000.00 | 65 100 000.00 | 77 800 000.00 | |
R6 Group Income (Consolidated Net Income) | 269 700 000.00 | 255 400 000.00 | 269 700 000.00 | |
R7 Share of minority interests (Non-group income) | -3 100 000.00 | -1 100 000.00 | -3 100 000.00 | |
R8 Net income, group share (parent company share) | 272 800 000.00 | 256 500 000.00 | 272 800 000.00 | |
